This mega-merger could be on the rocks following objections by high-profile investors.
Sales are skyrocketing at this small-cap marijuana stock, but its expenses are, too.
Here's how this marijuana stock is executing, as well as its plans for the future.
This marijuana stock just landed a consumer-goods Goliath as a strategic adviser.
New Jersey could clear the way for adult use of marijuana later this month.
The pot company could be on the cusp of a surge in sales next year following a key acquisition.
Spousal benefits are a valuable source of retirement income for millions, but not everyone can collect them.
Before investing in pot stocks, you'll want to know these three things.
The stock market has lost some momentum lately and that has marijuana stock investors jittery. Here are some steps to take if the sell-off worsens.
Roche and Biogen are spending big bucks on gene therapy biotech stocks.
The low-priced shares could be bargain-bin buys.
Gottlieb's resignation creates uncertainty following a successful tenure that balanced innovation and accountability.
Here are the most important things you should know before investing in pot stocks and cannabis companies.
The company got welcome support from a big money manager.
This company's epilepsy drug has been submitted for approval in the U.S. and Europe.
Investors are hopeful that this struggling biotech is about to get back on track.
The company's burning through cash, and that has investors nervous.
Stashing these top stocks in your income portfolio could pay off big in the coming decades.
A string of positive news on drugs in development sparked investor excitement.
The company offered up more disappointing data for its zinc-finger gene-editing platform.